minimum duration required between premedicating agents and inducing agents to decrease the dose required for inducing agent and to maintain better vital parameters
Phase 4
- Conditions
- Health Condition 1: null- Posted for surgery under general anaesthesia
- Registration Number
- CTRI/2017/08/009313
- Lead Sponsor
- Department of Anaesthesiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients belonging to American Society of Anesthesiologists physical status I & II
2.Patients undergoing neuro-surgery
3.Age group between 15 and 50 years
4.Haemodynamically stable
Exclusion Criteria
1.History of hypertension, diabetes or other systemic illness
2.History of drug or alcohol abuse
3.History of neurological disease
4.History of chronic use of opioid, antipsychotic, antidepressant, anxiolytic drug.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in dose of propofolTimepoint: 10 minutes
- Secondary Outcome Measures
Name Time Method Maintainance of hemodynamic parametersTimepoint: 10 minutes